-
Alternative name1
Anti-PRAME (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Alternative name2
PRAME (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Alternative name3
PRAME (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Alternative name4
PRAME
-
Alternative name5
Anti -PRAME (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Other names
PRAME; Melanoma antigen preferentially expressed in tumors; N/A; N/A; Opa-interacting protein 4; OIP-4; Preferentially expressed antigen of melanoma
-
Gene name
N/A
-
Gene name synonims
N/A
-
Other gene names
N/A; PRAME; N/A; MAPE; OIP4; OIP-4
-
Category
Antibodies
-
Clonality
Polyclonal
-
Immunoglobulin isotype
IgG
-
Clone
Polyclonal antibody
-
Host organism
Host: Mouse; Source: Human
-
Species reactivity
Human
-
Specificity and cross reactivity
Recognizes human PRAME.
-
Purification method
Affinity Purified by Protein A affinity chromatography.
-
Form Appearance
Supplied as a liquid in PBS, pH 7.2.
-
Concentration
N/A
-
Storage and shipping
Store at 4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, productone should be kept at -20 degrees Celsius. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
-
Tested for
Western Blot (WB)
-
Description
productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against. Properly used, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in. Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, they are inexpensive to manufacture and respectively to buy, the time needed for production is considerably shorter. Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions. To obtain more detailed information on productone, please, refer to the full product datasheet.
-
Advisory
In order to retain the quality and the affinity of productone unchanged, please, avoid cycles of freezing and thawing. For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube. Prior to use briefly centrifuge the vial to gather all the solution on the bottom.
-
Additional description
Antigens are peptides or recombinant or native dependent on the production method.
-
Gene target
-
Gene symbol
PRAME
-
Short name
PRAME (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Technique
antigen, antigenes
-
Alternative name
preferentially expressed antigen in melanoma (Preferentially Expressed protein on Melanoma, Melanoma protein Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Alternative technique
antigenes
-
Alternative to gene target
preferentially expressed antigen in melanoma, CT130 and MAPE and OIP-4 and OIP4, PRAME and IDBG-2240 and ENSG00000185686 and 23532, retinoic acid receptor binding, nuclei
-
-
Name
-
Concept
Scope note:
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
-
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
-
Qualifiers
diagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery